Adine

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Adine

Property Description
Active ingredient Norepinephrine (Noradrenaline)
Form Concentrated solution for infusion
Pharmacological class Sympathomimetic agent / Vasopressor
Common use Emergency management of severe low blood pressure (hypotension)
Origin Synthetic version of an endogenous hormone

Adine is a potent, prescription-only medicine containing the active pharmaceutical ingredient Norepinephrine, a critical agent used exclusively to manage severe, life-threatening low blood pressure in acute care settings. The drug is functionally classified as a sympathomimetic agent, meaning it structurally and functionally mimics the natural effects of the body's adrenaline-like hormones within the circulatory system. This classification indicates that the medicine provides critical support by acting on the body's stress response pathways. Adine is designated as an emergency medicine, a classification clinically recognized for its immediate, life-saving impact in maintaining hemodynamic stability during acute circulatory failure.

Adine's Pharmacological Class and Purpose as a Vasopressor

Adine's essential pharmacological classification is that of a Vasopressor, a specialized group of drugs whose general purpose is to increase and stabilize dangerously low blood pressure. The active substance, Norepinephrine (or Noradrenaline), is chemically a catecholamine that acts predominantly as an α-adrenergic agonist, causing widespread peripheral vasoconstriction. This action of vessel tightening is the primary way the medicine forces blood pressure back up. By increasing the resistance within the blood vessels, the drug ensures that vital organs maintain adequate blood flow and oxygenation when the body's circulatory system is compromised, a typical, neutral use scenario found in managing conditions like septic shock.

Composition and Dosage Form: Concentrated Solution for Infusion

The pharmaceutical identity of Adine is a single-product formulated as a sterile concentrated solution for infusion, supplied in ampoules. The active substance, often in the form of synthetic Norepinephrine Bitartrate, is a synthetic version of an endogenous hormone and neurotransmitter. This preparation is balanced in an aqueous solution, a differentiating factor from formulations requiring lipid-based solvents, and is suitable only for the specialized route of intravenous infusion, which is necessary for the continuous and precise control required for managing unstable blood pressure in severe, acute hypotensive states.

What side effects are possible with Adine?

Possible Side Effects and Safety Information

Adine (Norepinephrine) is a potent medicine whose safety profile is defined by its powerful blood pressure-raising action, as documented in official regulatory sources like the FDA and EMA. Adverse reactions are grouped by affected physiological systems and frequency.


Adverse Reaction Scope

Category Description
Most Common Reactions Hypertension (high blood pressure) and reflex bradycardia (slowed heart rate) are the most frequently documented adverse events.
System-Organ Classes Effects primarily involve Cardiac disorders, Vascular disorders, Nervous system disorders (e.g., anxiety, headache), and Administration site conditions (local tissue effects).
Serious Safety Concerns Officially documented serious risks include ischemic injury, cardiac arrhythmias, and gangrene of the extremities, the latter associated with prolonged or high-dose infusions.

Contextual Safety Notes

Official labels address specific safety patterns and patient populations:

  • Exposure-Related Patterns: Abrupt cessation of the infusion may lead to marked hypotension (severe blood pressure drop), reflecting a risk tied to the treatment's duration and conclusion.
  • Population Considerations: Caution is noted for older adults due to potential sensitivity. The label also advises constraints for patients with pre-existing occlusive vascular disease or those receiving certain concomitant medications.
  • Interaction Risk: Co-administration with drugs like MAO inhibitors or certain halogenated anesthetics carries the officially documented risk of severe, prolonged hypertension or ventricular arrhythmias, respectively.

These safety classifications emphasize that continuous physiological monitoring is necessary to manage the drug's predictable cardiovascular effects and to mitigate the risks of severe vascular complications, as structured by government regulatory documents.

Overdose and Emergency Response

The official documentation defines Adine (Norepinephrine) overdosage as an event leading to acute circulatory over-stimulation, which must be addressed with immediate medical intervention.

Documented Overdose Manifestations

Overdose manifestations are primarily characterized by signs of excessive peripheral vasoconstriction and include severe hypertension, reflex bradycardia, decreased cardiac output, and a marked increase in peripheral resistance. The patient may present with acute symptoms such as violent headache, photophobia, intense sweating, pallor, and vomiting. Severe, life-threatening outcomes documented in regulatory labeling include intracranial hemorrhage, pulmonary edema, myocardial necrosis, ventricular dysrhythmias, and gangrene resulting from severe, prolonged peripheral ischemia. Population-specific notes state that hypersensitive persons may experience severe hypertension even at conventional doses.

Emergency Actions and Help-Seeking

Immediate medical help is required upon the observation of excessive blood pressure elevation, which is the critical indicator of overdosage. When overdosage is suspected, the regulatory mandate is to discontinue the infusion immediately and initiate appropriate corrective treatment. Constant monitoring of the patient's blood pressure and rate of flow is required, and the patient should not be left unattended. While no specific systemic antidote is described, an adrenergic blocking agent is mandated for local infiltration if extravasation, a complication leading to tissue necrosis, occurs.

Therapeutic Uses of Adine

What Adine Treats: Main Uses and Benefits

Adine (Norepinephrine) is focused on providing support during severe circulatory crises, addressing critical symptom domains that create noticeable physiological strain.

Adine is primarily applied in settings marked by heightened systemic burden, specifically for acute hypotension that is profound, which may be used when short-term symptomatic assistance is needed after initial treatments. The medication is commonly used for symptomatic support in conditions characterized by periods of heightened symptoms, such as septic shock, and is applied as an adjunct during emergency situations like cardiac arrest resuscitation and hypotension following spinal anesthesia.

This agent contributes to raising and stabilizing systemic blood pressure, which may assist with maintaining functional stability by supporting blood flow to vital organs. The support is relevant for easing severe symptoms related to systemic imbalance, such as those linked to organ-specific functional stress.

“The support provided by Adine is often critical when blood pressure instability becomes life-threatening.”


Quick Fact: Relief for Profound Hypotension

Adine is considered relevant when short-term symptomatic assistance is needed during acute episodes involving dangerously low blood pressure.

Eligibility and Restrictions for Use

Who Can and Cannot Use Adine?

Eligibility for Adine (Norepinephrine) is strictly determined by regulatory rules that focus on acute physiological status and absolute contraindications.

Contraindications and Prohibited Use

Adine is contraindicated in patients with hypotension due to uncorrected blood volume deficits (hypovolemia), except when used as a temporary emergency measure to sustain vital organ perfusion. It must not be used alongside Cyclopropane or Halothane anesthesia due to the high risk of severe ventricular arrhythmias. Use is also prohibited in individuals with a known hypersensitivity to norepinephrine or excipients like sodium metabisulfite.

Age-Related and Conditional Eligibility

Population Regulatory Status
Adult Patients Use is formally established and indicated.
Pediatric Patients Safety and effectiveness have not been established.
Pregnancy Given only if the potential benefit justifies the potential risk to the fetus, as it may impair placental perfusion.
Vascular Thrombosis Use is avoided (unless life-saving) due to the risk of extending ischemia/infarction.

Older adult patients require careful consideration, and infusion into the veins of the leg should be avoided in those with occlusive vascular disease.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Adine (Norepinephrine) interactions are classified based on the regulatory impact they have on the drug's vasopressor activity and clearance. These are predominantly severe, pharmacodynamic interactions documented in government prescribing information.

Formally Restricted Combinations

Co-administration is restricted or classified as a contraindicated combination with specific medicinal products due to the risk of severe cardiovascular events:

  • Monoamine Oxidase Inhibitors (MAOIs): Both non-selective MAOIs and drugs with MAO-inhibiting properties, such as Linezolid, are restricted. This is due to the inhibition of Norepinephrine's clearance, which results in a documented increase in drug exposure and the risk of severe, sustained hypertension.
  • Halogenated Anesthetics: Specific agents like Halothane or Cyclopropane are restricted because they sensitize the heart muscle, significantly increasing the risk of life-threatening ventricular arrhythmias.

Agents that Potentiate Effects

Tricyclic Antidepressants (TCAs) are documented to potentiate the pressor response by blocking the neuronal reuptake of Norepinephrine, which can lead to severe hypertension. Other Sympathomimetic Agents, Ergot Alkaloids, and Oxytocin also exhibit an additive pharmacodynamic effect, reinforcing the blood pressure-raising action.

No interactions with food, alcohol, or herbal products are formally documented in the regulatory prescribing information for this continuous intravenous medicine.

Mechanism of Action

How Adine Works


The action of Norepinephrine is defined by its role as a direct agonist at specific adrenergic receptors, generating immediate and significant physiological changes.

Vascular Resistance Modulation by alpha1-Agonism

This primary domain involves the drug's direct engagement with alpha1-adrenergic receptors found on the smooth muscle of blood vessels. By initiating a specific intracellular calcium cascade, this mechanism triggers immediate and widespread vasoconstriction. The result is a substantial increase in Systemic Vascular Resistance (SVR), which directly elevates Mean Arterial Pressure (MAP).

️ Direct Cardiac Force Enhancement

The secondary domain involves the activation of beta1-adrenergic receptors within the heart muscle. This interaction enhances the force of myocardial contraction, known as the positive inotropic effect. This mechanism contributes to the heart's pumping action by increasing contractile force (inotropy), which supports the pressure effect established by the vascular resistance.

Constraints on Mechanistic Effectiveness

The action of Norepinephrine is intrinsically linked to the chemical environment of the receptor. The effectiveness of the alpha1 and beta1 agonism can be significantly attenuated by severe tissue acidosis or hypoxia, limiting the expected vasoconstrictive and inotropic responses. This indicates that the pressor mechanism is functionally dependent on functional receptor physiology.

Dosage and Administration Information

Adine (which may be a combination of agents like a nonsteroidal anti-inflammatory drug (NSAID) and paracetamol) must be taken exactly as prescribed by a healthcare professional. The dose, frequency, and duration of use are determined by the treating physician based on the specific medical condition and the patient's response to therapy. Patients should not modify their dosage or stop the medication without consulting their doctor.

Administration Guidelines

Action Instruction
With or Without Food Take the tablet with or immediately after food to help minimize the risk of gastrointestinal irritation and stomach upset.
Tablet Integrity Swallow the tablet whole. Do not chew, crush, or break the tablet, as this can affect the way the medicine is absorbed and its effectiveness.
Missed Dose If a regular dose is missed, take it as soon as it is remembered. However, if it is nearly time for the next scheduled dose, skip the missed dose and continue the regular dosing schedule. Do not take a double dose to compensate for the missed one.

Safety Precautions

To ensure proper and safe use, adhere to all directions provided on the prescription label. It is important to utilize the lowest effective dose for the shortest necessary duration to mitigate potential risks, particularly those related to gastrointestinal and cardiovascular health. Do not exceed the prescribed dose or duration of treatment, as this may increase the chance of experiencing serious side effects, including liver damage, especially if the formulation contains paracetamol.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Adine (Norepinephrine)

This section provides a non-advisory overview of the research studies and evidence landscape that contribute to Adine's use in acute critical care settings, drawing only on official regulatory and scientific literature. The research described focuses strictly on study design, measured outcomes, and documented limitations, and does not offer clinical recommendations or safety advice.


Research Evidence for Severe Low Blood Pressure in Septic Shock

The most extensive research contributes to the research base for Adine, where studies examined its use in patients experiencing severe low blood pressure due to septic shock. Research has relied on numerous Randomized Controlled Trials (RCTs) and subsequent Systematic Reviews which compared Adine to other medicines evaluated for their effect on blood pressure.

These studies focused primarily on adult patients in the Intensive Care Unit (ICU) and examined outcomes related to overall survival and blood pressure levels. Data show patterns related to blood pressure levels monitored during the study period. Comparative studies explored Adine's use as an initial agent during periods of acute or disruptive episodes of low blood pressure.


Evidence for Blood Pressure Support in Cardiogenic Shock

Research for Adine's role in low blood pressure resulting from cardiogenic shock includes Systematic Reviews and subgroup analyses from multi-center trials, which explored outcomes in adult patients after events like a heart attack.

These studies examined outcomes related to systemic or functional imbalance by measuring changes in blood pressure, heart rate, and other markers of function. Research highlights changes measured during the study period related to achieving target blood pressure levels. Sample sizes were modest in some dedicated comparative RCTs for this specific indication. Evidence quality varies across studies, and dedicated research focusing solely on this specific type of shock is still emerging.


What the Research Indicates is Still Uncertain

  • Post-Cardiac Arrest: For patients experiencing low blood pressure following cardiac arrest, the evidence is often derived from smaller cohorts and observational reports. Definitive data on Adine's influence on neurological outcome and long-term survival in this specific, complex scenario are still emerging.
  • Limited Information for Long-Term Outcomes: The research focus on acute, short-term stabilization means the long-term effects are not fully established, and functional recovery is not a direct outcome measured in the majority of regulatory-supporting trials.

Key Studies & References Timing of norepinephrine initiation in patients with septic shock: a systematic review and meta-analysis

Frequently Asked Questions (FAQ)

Common questions about Adine (FAQ)


Q: How quickly should I expect Adine to start working?

A: Adine (Norepinephrine) has a very rapid onset of action because it is administered through a continuous intravenous infusion. According to official drug information, the concentration of the medicine in the blood reaches a steady-state approximately five minutes after the infusion is started. This characteristic helps healthcare providers manage acute, severe low blood pressure efficiently.


Q: Can Adine make you feel tired or drowsy?

A: Regulatory documents do not specifically list profound drowsiness or fatigue as a primary common side effect. However, they do note that patients may experience unusual tiredness or weakness. Other central nervous system effects, such as headache or anxiety, are also listed in regulatory documents.


Q: What does the 'active ingredient' in Adine actually do?

A: The active ingredient in Adine, Norepinephrine, is classified as a vasopressor—a medicine that helps raise blood pressure. It primarily works by stimulating specific receptors to cause widespread constriction (narrowing) of blood vessels. This action, along with increasing the heart's pumping force, is how the medicine supports and stabilizes blood pressure during periods of acute hypotension.


Q: Can a pregnant woman safely use Adine?

A: Official information states that Norepinephrine may be given during pregnancy only if the healthcare provider determines that the potential benefit to the mother justifies the potential risk to the fetus. The drug carries a risk because it may potentially cause a decrease in blood flow to the placenta. This conditional use means that the treating physician must carefully weigh the urgency of treating the mother's condition against the potential risks to the fetus.


Q: Is Adine safe for use while breastfeeding?

A: There is limited official information regarding the use of Norepinephrine during breastfeeding. Since the drug has a very short half-life and is poorly absorbed when taken orally, it is unlikely that any amount transferred into breast milk would significantly affect the infant. A healthcare provider assesses the risk-benefit profile when making a decision about use during breastfeeding.


Q: Can Adine interfere with a cholesterol-lowering medication?

A: The official drug label focuses primarily on severe interactions with medicines such as MAO inhibitors and certain tricyclic antidepressants. It is not known to generally interfere with common cholesterol-lowering medications, but it is important that healthcare providers are aware of all medications being administered, including prescription and over-the-counter products.


Q: Can I take Adine with pain relievers like ibuprofen?

A: Regulatory guidelines recommend that patients discuss all medications, including over-the-counter products, with their healthcare provider. The combination of Norepinephrine with Nonsteroidal Anti-inflammatory Drugs (NSAIDs), such as ibuprofen, has been associated with a potential increase in the risk or severity of hypertension.


Q: Is Adine a common over-the-counter medication?

A: No, Adine is not an over-the-counter medication. It is a prescription-only medicine classified as an emergency drug. It is administered only by continuous intravenous infusion, requiring use in a specialized hospital setting to manage severe low blood pressure.


Q: Can children or teenagers be prescribed Adine?

A: Official information from the FDA states that the safety and effectiveness of Norepinephrine in pediatric patients have not been formally established. Use in pediatric patients may occur under the guidance and direct supervision of a specialized clinician and requires continuous monitoring, despite the lack of established safety data.


Q: Are there generic versions of Adine available?

A: Yes. Norepinephrine (the active pharmaceutical ingredient in Adine) is available from various manufacturers as an approved generic drug. It is commonly supplied as a generic injection solution or as a ready-to-use premixed formulation.


Q: Is it okay to take Adine before bedtime?

A: Adine is not a medicine taken at a set time, such as before bedtime. It is administered as a continuous intravenous infusion for severe, acute medical conditions that require constant monitoring in a hospital setting. The infusion rate is continuously adjusted by healthcare professionals to maintain the necessary blood pressure.


Q: Is Adine known to interact with herbal supplements?

A: The official label does not document specific interactions with most common herbal products. However, regulatory guidelines recommend that patients discuss all medications and herbal products with a healthcare provider before use, as a general safety precaution.


Q: Are there any specific warnings for diabetic patients taking Adine?

A: Yes. Patients being treated with antidiabetic agents require close monitoring of their blood glucose concentration during treatment with Adine. This is because official product information indicates that Norepinephrine may affect blood sugar levels. The patient's clinical team will determine if any adjustments to their diabetes treatment are needed.


Q: How frequently is Adine usually dosed?

A: Adine is administered via a continuous intravenous infusion for acute blood pressure support. The infusion rate is constantly monitored and 'titrated' (adjusted) by a healthcare professional to achieve and maintain the required blood pressure level, rather than being given at set time intervals.


Q: What does the patient information leaflet for Adine usually contain?

A: Official patient information leaflets are structured to provide comprehensive data on the drug, as required by regulatory bodies. They typically contain sections detailing the medicine's approved uses, important warnings, possible adverse reactions, how the medicine is supplied, and storage and handling instructions.


Q: What is the typical timeframe before Adine's full effect is noticed?

A: The medicine is designed for rapid action in acute settings. According to official pharmacokinetic data, the plasma concentration that results in the full expected effect (steady-state) is reached within approximately five minutes after the start of the continuous infusion.


Q: Does Adine require any special storage conditions?

A: Yes. The concentrated solution for infusion must be stored at a Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). It is also essential that the vials are protected from light by being stored in their original carton.


Q: What if I vomit shortly after taking Adine?

A: Adine is administered strictly by continuous intravenous infusion, meaning it is injected directly into the bloodstream, completely bypassing the digestive system. Therefore, vomiting does not interfere with the absorption or delivery of the medicine into the bloodstream.


Q: Is Adine known to cause stomach upset or nausea?

A: Regulatory documents classify nausea and vomiting as reported side effects associated with the use of Norepinephrine. Patients experiencing such effects typically inform the healthcare provider monitoring their treatment.

How should Adine be stored and disposed of?

How to Store and Dispose of Adine (Norepinephrine Bitartrate Injection)

The official storage and disposal requirements for Adine injection are set by regulatory agencies to maintain its critical potency and sterility.

Storage Requirements

  • Temperature and Light: Store the concentrated solution at Controlled Room Temperature, specifically 20 C to 25 C (68 F to 77 F), and protect from light.
  • Container and Inspection: Keep the vials in the original carton. Before use, the solution must be visually inspected; do not use if it is discolored or contains a precipitate.
  • Stability: Once diluted for infusion, the solution should be used immediately from a microbiological safety perspective. Chemical and physical stability has been demonstrated for up to 24 hours at 25 C.

Disposal and Safety

  • Discarding: Any unused portion of the concentrated or diluted solution must be discarded.
  • Waste Handling: Disposal of the unused product and associated waste material must be carried out in accordance with local requirements.
  • Child Safety: All medicine must be kept out of the sight and reach of children.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Adine found in:

A-Z Index: